Hydroxylation of p-nitrophenol by rabbit ethanol-inducible cytochrome P- 450 isozyme 3a

DR Koop

The hydroxylation of p-nitrophenol to 4-nitrocatechol was investigated using rabbit hepatic microsomes and six purified isozymes of cytochrome P-450. The microsomal activity was maximal at pH 6.8 and at 100 microM p-nitrophenol. At higher substrate concentrations inhibition was observed. At pH 6.8 and 100 microM p-nitrophenol, isozyme 3a exhibited the highest activity of the purified isozymes: 3.4-fold more active than isozyme 6, and 8-fold more active than isozymes 2 and 4. The isozyme 3a-catalyzed hydroxylation reaction was stimulated 2.4-fold by the addition of a 4:1 ratio of cytochrome b5/P-450. At optimal concentrations of cytochrome b5, isozyme 3a was 8- to 9-fold more active than isozymes 2 and 6 and 20-fold more active than isozyme 4. Under the same conditions, isozyme 3a-catalyzed butanol oxidation was inhibited 40%. Antibodies to isozyme 3a inhibited greater than 95% of the p-nitrophenol hydroxylase activity of microsomes from untreated or from ethanol- or acetone-treated rabbits. The microsomal hydroxylase activity was linearly correlated with the microsomal concentration of isozyme 3a (correlation coefficient of 0.94) and had an intercept near zero. The results from reconstitution, antibody inhibition, and correlation experiments indicate that isozyme 3a is the principal catalyst of rabbit microsomal p-nitrophenol hydroxylation. The ability of the ethanol-inducible isozyme to catalyze catechol formation may be important in the ethanol-enhanced toxicity of aromatic compounds such as benzene.

Volume 29, Issue 4, pp. 399-404, 04/01/1986
Copyright © 1986 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				S. L. Collom, R. M. Laddusaw, A. M. Burch, P. Kuzmic, M. D. Perry Jr., and G. P. Miller CYP2E1 Substrate Inhibition: MECHANISTIC INTERPRETATION THROUGH AN EFFECTOR SITE FOR MONOCYCLIC COMPOUNDS J. Biol. Chem., February 8, 2008; 283(6): 3487 - 3496. [Abstract] [Full Text] [PDF]

				S. N. Kim, J. Y. Seo, D. W. Jung, M. Y. Lee, Y. S. Jung, and Y. C. Kim Induction of Hepatic CYP2E1 by a Subtoxic Dose of Acetaminophen in Rats: Increase in Dichloromethane Metabolism and Carboxyhemoglobin Elevation Drug Metab. Dispos., October 1, 2007; 35(10): 1754 - 1758. [Abstract] [Full Text] [PDF]

				G. Cherala, B. H. Shapiro, and A. P. D'mello Effect of Perinatal Low Protein Diets on the Ontogeny of Select Hepatic Cytochrome P450 Enzymes and Cytochrome P450 Reductase in the Rat Drug Metab. Dispos., July 1, 2007; 35(7): 1057 - 1063. [Abstract] [Full Text] [PDF]

				J. N. Baumgardner, K. Shankar, S. Korourian, T. M. Badger, and M. J. J. Ronis Undernutrition enhances alcohol-induced hepatocyte proliferation in the liver of rats fed via total enteral nutrition Am J Physiol Gastrointest Liver Physiol, July 1, 2007; 293(1): G355 - G364. [Abstract] [Full Text] [PDF]

				A Vences-Mejia, N Labra-Ruiz, N Hernandez-Martinez, V Dorado-Gonzalez, J Gomez-Garduno, I Perez-Lopez, R Nosti-Palacios, R C. Carranza, and J. Espinosa-Aguirre The Effect of Aspartame on Rat Brain Xenobiotic-Metabolizing Enzymes Human and Experimental Toxicology, August 1, 2006; 25(8): 453 - 459. [Abstract] [PDF]

				T. R. Fennell, R. W. Snyder, C. Parkinson, J. Murphy, and R. A. James The Effect of Ethylene Exposure on Ethylene Oxide in Blood and on Hepatic Cytochrome P450 in Fischer Rats Toxicol. Sci., September 1, 2004; 81(1): 7 - 13. [Abstract] [Full Text] [PDF]

				A. C. Simmonds, B. I. Ghanayem, A. Sharma, C. A. Reilly, B. Millen, G. S. Yost, and P.-G. Forkert Bioactivation of 1,1-Dichloroethylene by CYP2E1 and CYP2F2 in Murine Lung J. Pharmacol. Exp. Ther., September 1, 2004; 310(3): 855 - 864. [Abstract] [Full Text] [PDF]

				M. J. J. Ronis, S. Korourian, M. Zipperman, R. Hakkak, and T. M. Badger Dietary Saturated Fat Reduces Alcoholic Hepatotoxicity in Rats by Altering Fatty Acid Metabolism and Membrane Composition J. Nutr., April 1, 2004; 134(4): 904 - 912. [Abstract] [Full Text] [PDF]

				R. Montero, L. Serrano, V. M. Davila, A. Ito, and A. Plancarte Infection of rats with Taenia taeniformis metacestodes increases hepatic CYP450, induces the activity of CYP1A1, CYP2B1 and COH isoforms and increases the genotoxicity of the procarcinogens benzo[a]pyrene, cyclophosphamide and aflatoxin B1 Mutagenesis, March 1, 2003; 18(2): 211 - 216. [Abstract] [Full Text] [PDF]

				L. Cancino-Badias, R.E. Reyes, R. Nosti, I. Perez, V. Dorado, S. Caballero, A. Soria, R. Camacho-Carranza, D. Escobar, and J.J. Espinosa-Aguirre Modulation of rat liver citochrome P450 by protein restriction assessed by biochemical and bacterial mutagenicity methods Mutagenesis, January 1, 2003; 18(1): 95 - 100. [Abstract] [Full Text] [PDF]

				R. A. Graham, A. Downey, D. Mudra, L. Krueger, K. Carroll, C. Chengelis, A. Madan, and A. Parkinson In Vivo and in Vitro Induction of Cytochrome P450 Enzymes in Beagle Dogs Drug Metab. Dispos., November 1, 2002; 30(11): 1206 - 1213. [Abstract] [Full Text] [PDF]

				Z. Zhou, X. Sun, and Y. James Kang Metallothionein Protection against Alcoholic Liver Injury through Inhibition of Oxidative Stress Experimental Biology and Medicine, March 1, 2002; 227(3): 214 - 222. [Abstract] [Full Text] [PDF]

				D. A. Chakkalakal, J. R. Novak, E. D. Fritz, T. J. Mollner, D. L. McVicker, D. L. Lybarger, M. H. McGuire, and T. M. Donohue Jr CHRONIC ETHANOL CONSUMPTION RESULTS IN DEFICIENT BONE REPAIR IN RATS Alcohol Alcohol., January 1, 2002; 37(1): 13 - 20. [Abstract] [Full Text] [PDF]

				A. A. Nanji, K. Jokelainen, G. K. K. Lau, A. Rahemtulla, G. L. Tipoe, R. Polavarapu, and E.-N. Lalani Arginine Reverses Ethanol-Induced Inflammatory and Fibrotic Changes in Liver Despite Continued Ethanol Administration J. Pharmacol. Exp. Ther., December 1, 2001; 299(3): 832 - 839. [Abstract] [Full Text] [PDF]

				T. R. Van Vleet, D. W. Bombick, and R. A. Coulombe Jr. Inhibition of Human Cytochrome P450 2E1 by Nicotine, Cotinine, and Aqueous Cigarette Tar Extract in Vitro Toxicol. Sci., December 1, 2001; 64(2): 185 - 191. [Abstract] [Full Text] [PDF]

				D. Escobar-Garcia, R. Camacho-Carranza, I. Perez, V. Dorado, M. Arriaga-Alba, and J.J. Espinosa-Aguirre S9 induction by the combined treatment with cyclohexanol and albendazole Mutagenesis, November 1, 2001; 16(6): 523 - 528. [Abstract] [Full Text] [PDF]

				M. J. Myers, D. E. Farrell, K. D. Howard, and J. C. Kawalek Identification of Multiple Constitutive and Inducible Hepatic Cytochrome P450 Enzymes in Market Weight Swine Drug Metab. Dispos., June 1, 2001; 29(6): 908 - 915. [Abstract] [Full Text]

				P.-G. Forkert, S. M. Boyd, and J. B. Ulreich Pulmonary Bioactivation of 1,1-Dichloroethylene Is Associated with CYP2E1 Levels in A/J, CD-1, and C57BL/6 Mice J. Pharmacol. Exp. Ther., June 1, 2001; 297(3): 1193 - 1200. [Abstract] [Full Text]

				H. Kim, D. A. Putt, R. C. Zangar, C. R. Wolf, F. P. Guengerich, R. J. Edwards, P. F. Hollenberg, and R. F. Novak Differential Induction of Rat Hepatic Cytochromes P450 3A1, 3A2, 2B1, 2B2, and 2E1 in Response to Pyridine Treatment Drug Metab. Dispos., March 1, 2001; 29(3): 353 - 360. [Abstract] [Full Text]

				A. P. Titis and P.-G. Forkert Strain-Related Differences in Bioactivation of Vinyl Carbamate and Formation of DNA Adducts in Lungs of A/J, CD-1, and C57BL/6 Mice Toxicol. Sci., January 1, 2001; 59(1): 82 - 91. [Abstract] [Full Text] [PDF]

				J. C. Rowlands, H. Wang, R. Hakkak, M. J. J. Ronis, H. W. Strobel, and T. M. Badger Chronic Intragastric Infusion of Ethanol-Containing Diets Induces CYP3A9 While Decreasing CYP3A2 in Male Rats J. Pharmacol. Exp. Ther., November 1, 2000; 295(2): 747 - 752. [Abstract] [Full Text]

				M A Gyamfi, N Hokama, K Oppong-Boachie, and Y Aniya Inhibitory effects of the medicinal herb, Thonningia san gunea, on liver drug metabolizing enzymes of rats Human and Experimental Toxicology, November 1, 2000; 19(11): 623 - 631. [Abstract] [PDF]

				T. Wang, K. Shankar, M. J. J. Ronis, and H. M. Mehendale Potentiation of Thioacetamide Liver Injury in Diabetic Rats Is Due to Induced CYP2E1 J. Pharmacol. Exp. Ther., August 1, 2000; 294(2): 473 - 479. [Abstract] [Full Text]

				P. D. Premdas, R. J. Bowers, and P.-G. Forkert Inactivation of Hepatic CYP2E1 by an Epoxide of Diallyl Sulfone J. Pharmacol. Exp. Ther., June 1, 2000; 293(3): 1112 - 1120. [Abstract] [Full Text]

				V. Arora and P. L. Iversen Antisense Oligonucleotides Targeted to the p53 Gene Modulate Liver Regeneration In Vivo Drug Metab. Dispos., February 1, 2000; 28(2): 131 - 138. [Abstract] [Full Text]

				J. Q. Dong, A. S. Etheridge, and P. C. Smith Effect of Selective Phase II Enzyme Inducers on Glucuronidation of Benoxaprofen in Rats Drug Metab. Dispos., December 1, 1999; 27(12): 1423 - 1428. [Abstract] [Full Text]

				K. Rockich and R. Blouin Effect of the Acute-Phase Response on the Pharmacokinetics of Chlorzoxazone and Cytochrome P-450 2E1 In Vitro Activity in Rats Drug Metab. Dispos., September 1, 1999; 27(9): 1074 - 1077. [Abstract] [Full Text]

				M. R. Lovern, M. E. Maris, and P. M. Schlosser Use of a mathematical model of rodent in vitro benzene metabolism to predict human in vitro metabolism data Carcinogenesis, August 1, 1999; 20(8): 1511 - 1520. [Abstract] [Full Text] [PDF]

				D. Pankow and B. Damme Carbon Monoxide Generation from Trihalomethane Metabolism in Rats Indoor and Built Environment, May 1, 1999; 8(3): 203 - 208. [Abstract] [PDF]

				T. F. Dowsley, K. Reid, D. Petsikas, J. B. Ulreich, R. L. Fisher, and P.-G. Forkert Cytochrome P-450-Dependent Bioactivation of 1,1-Dichloroethylene to a Reactive Epoxide in Human Lung and Liver Microsomes J. Pharmacol. Exp. Ther., May 1, 1999; 289(2): 641 - 648. [Abstract] [Full Text]

				T. C. Sarich, S. P. Adams, G. Petricca, and J. M. Wright Inhibition of Isoniazid-Induced Hepatotoxicity in Rabbits by Pretreatment with an Amidase Inhibitor J. Pharmacol. Exp. Ther., May 1, 1999; 289(2): 695 - 702. [Abstract] [Full Text]

				M. B. Sewer and E. T. Morgan Down-Regulation of the Expression of Three Major Rat Liver Cytochrome P450S by Endotoxin In Vivo Occurs Independently of Nitric Oxide Production J. Pharmacol. Exp. Ther., October 1, 1998; 287(1): 352 - 358. [Abstract] [Full Text]

				M. B. Sewer, T. B. Barclay, and E. T. Morgan Down-Regulation of Cytochrome P450 mRNAs and Proteins in Mice Lacking a Functional NOS2 Gene Mol. Pharmacol., August 1, 1998; 54(2): 273 - 279. [Abstract] [Full Text]